About Microbiotica
Microbiotica is a company based in Cambridge (United Kingdom) founded in 2016 by Gordon Dougan and Trevor Lawley.. Microbiotica has raised $82.84 million across 3 funding rounds from investors including Tencent, IP Group and Flerie. The company has 42 employees as of December 31, 2020. Microbiotica offers products and services including MB097 and MB310. Microbiotica operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Biogen, Alnylam and ATAI, among others.
- Headquarter Cambridge, United Kingdom
- Employees 42 as on 31 Dec, 2020
- Founders Gordon Dougan, Trevor Lawley
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Microbiotica Limited
- Date of Incorporation 08 Jul, 2016
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$82.84 M (USD)
in 3 rounds
-
Latest Funding Round
$67 M (USD), Series B
Mar 07, 2022
-
Investors
Tencent
& 6 more
-
Employee Count
42
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Microbiotica
Microbiotica offers a comprehensive portfolio of products and services, including MB097 and MB310. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Co-therapy with KEYTRUDA for advanced melanoma treatment.
Therapy for ulcerative colitis to improve patient outcomes.
Unlock access to complete
Unlock access to complete
Funding Insights of Microbiotica
Microbiotica has successfully raised a total of $82.84M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $67 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $67.0M
-
First Round
First Round
(15 Dec 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series B - Microbiotica | Valuation | Flerie , Tencent | |
| May, 2018 | Amount | Series A - Microbiotica | Valuation | Seventure Partners |
|
| Dec, 2016 | Amount | Series A - Microbiotica | Valuation | IP Group , Cambridge Innovation Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Microbiotica
Microbiotica has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, IP Group and Flerie. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Flerie is engaged in investing in biotech and pharmaceutical companies.
|
Founded Year | Domain | Location | |
|
Venture capital co-investments are made in UK later-stage businesses.
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in life sciences and deep tech.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Microbiotica
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Microbiotica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Microbiotica Comparisons
Competitors of Microbiotica
Microbiotica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Biogen, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Microbiotica
Frequently Asked Questions about Microbiotica
When was Microbiotica founded?
Microbiotica was founded in 2016.
Where is Microbiotica located?
Microbiotica is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Microbiotica a funded company?
Microbiotica is a funded company, having raised a total of $82.84M across 3 funding rounds to date. The company's 1st funding round was a Series A of $10.4M, raised on Dec 15, 2016.
How many employees does Microbiotica have?
As of Dec 31, 2020, the latest employee count at Microbiotica is 42.
What does Microbiotica do?
Microbiotica was founded in 2016 and is headquartered in Cambridge, United Kingdom. Operations focus on the biotechnology sector, where gut bacteria associated with specific phenotypes are identified to support the development of live bacterial therapeutics and biomarkers. These efforts target inflammatory bowel disease, immuno-oncology, and gut epithelial barrier repair, with precision applied to phenotype linkages for therapeutic applications.
Who are the top competitors of Microbiotica?
Microbiotica's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Microbiotica offer?
Microbiotica offers MB097 and MB310.
Who are Microbiotica's investors?
Microbiotica has 7 investors. Key investors include Tencent, IP Group, Flerie, British Patient Capital, and Cambridge Innovation Capital.
What is Microbiotica's valuation?
The valuation of Microbiotica is $37.34M as of May 2018.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.